Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies

被引:16
作者
Jensen, Jeffrey [1 ]
Mansour, Diana [2 ]
Lukkari-Lax, Eeva [3 ]
Inki, Pirjo [4 ]
Burock, Karin [5 ]
Fraser, Ian S. [6 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA
[2] New Croft Ctr, Newcastle Upon Tyne NE1 6ND, Tyne & Wear, England
[3] Bayer Oy, Espoo 02151, Finland
[4] Bayer HealthCare, Turku 20101, Finland
[5] Bayer HealthCare, D-42096 Wuppertal, Germany
[6] Univ Sydney, Sydney, NSW 2006, Australia
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
Amenorrhea; Contraception; Heavy menstrual bleeding; Levonorgestrel-releasing intrauterine system (LNG-IUS); BLOOD-LOSS; IDIOPATHIC MENORRHAGIA; ENDOMETRIAL RESECTION; COMPARATIVE TRIAL; SAFETY;
D O I
10.1016/j.contraception.2012.08.022
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The study was conducted to characterize the changes in bleeding pattern over time in women receiving the levonorgestrelreleasing intrauterine system (LNG-IUS) for heavy menstrual bleeding (HMB). The reduction in menstrual blood loss volume has been well documented elsewhere. Study Design: Post hoc pooled analysis of the impact of the LNG-IUS on bleeding patterns in four comparator studies of medical and surgical treatment options for HMB. We enrolled women aged >= 18 years with HMB without organic pathology. The change in the number of bleeding and spotting (B/S) days and bleeding patterns was assessed over the duration of the studies pooled. Results: One hundred and sixty-three women received the LNG-IUS in randomized trials. Relative to pretreatment baseline, there was a transient increase in the mean number of bleeding days in the first month of treatment, which returned to baseline by the second month and declined thereafter. Although the number of spotting days also increased during the first month of treatment, these declined with continued use but remained elevated relative to baseline during the first year of treatment. Conclusion: In women with HMB, the LNG-IUS is associated with an initial increase in number of B/S days that improve over time. (c) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:107 / 112
页数:6
相关论文
共 23 条
  • [1] LEVONORGESTREL-RELEASING INTRAUTERINE-DEVICE IN THE TREATMENT OF MENORRHAGIA
    ANDERSSON, JK
    RYBO, G
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (08): : 690 - 694
  • [2] LEVONORGESTREL-RELEASING AND COPPER-RELEASING (NOVA T) IUDS DURING 5 YEARS OF USE - A RANDOMIZED COMPARATIVE TRIAL
    ANDERSSON, K
    ODLIND, V
    RYBO, G
    [J]. CONTRACEPTION, 1994, 49 (01) : 56 - 72
  • [3] Pregnancy during the use of levonorgestrel intrauterine system
    Backman, T
    Rauramo, I
    Huhtala, S
    Koskenvuo, M
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (01) : 50 - 54
  • [4] Advance information improves user satisfaction with the levonorgestrel intrauterine system
    Backman, T
    Huhtala, S
    Luoto, R
    Tuominen, J
    Rauramo, I
    Koskenvuo, M
    [J]. OBSTETRICS AND GYNECOLOGY, 2002, 99 (04) : 608 - 613
  • [5] THE ANALYSIS OF VAGINAL BLEEDING PATTERNS INDUCED BY FERTILITY REGULATING METHODS
    BELSEY, EM
    MACHIN, D
    DARCANGUES, C
    [J]. CONTRACEPTION, 1986, 34 (03) : 253 - 260
  • [6] Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report
    Cox, M
    Tripp, J
    Blacksell, S
    [J]. JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2002, 28 (02) : 73 - 77
  • [7] Fraser IS., 2009, EXPERT REV OBSTET GY, V4, P179, DOI DOI 10.1586/17474108.4.2.179
  • [8] Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS)-a multicentre prospective study
    Gemzell-Danielsson, K.
    Inki, P.
    Boubli, L.
    O'Flynn, M.
    Kunz, M.
    Heikinheimo, O.
    [J]. HUMAN REPRODUCTION, 2010, 25 (02) : 354 - 359
  • [9] A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena
    Gemzell-Danielsson, Kristina
    Schellschmidt, Ilka
    Apter, Dan
    [J]. FERTILITY AND STERILITY, 2012, 97 (03) : 616 - U121
  • [10] DETERMINATION OF MENSTRUAL BLOOD LOSS
    HALLBERG, L
    NILSSON, L
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1964, 16 (02) : 244 - &